HIV/AIDS Activist Fears Pacific-Region Trade Talks Will Raise Drug Costs
This article was originally published in PharmAsia News
An HIV/AIDS activist in Malaysia said he is concerned that HIV/AIDS drugs newly available at a relatively reasonable cost could rise out of sight again as a result of trade talks among the nine Pacific-region nations.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.